run coming?

Now that ftt is fully funded for the current trial is it time for it to go for a run?

Results are getting nearer and success is expected (although never guaranteed).

I'm a biotech investor, and the sector hasn't looked so go for ages, following successful deals and trials.

ftt has a large market, and it's one that could save health authorities heaps, let alone benefit patients - so it'll certainly be attractive.

I suggest buy at 4c and get set for the results.

all imho.

Cheers